Skip to main content

Prostate – MEVPRO-1

Trial ID
NCT06551324
Trial Sponsor
Pfizer

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). (MEVPRO-1)

Patients, we are no longer accepting cash payments.

X